Tempest Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -155 | -88 | -85 | -510 |
EBITDA | -9,427 | -7,886 | -7,429 | -6,592 |
EBIT | -9,582 | -7,974 | -7,514 | -7,102 |
Net Income | -9,570 | -7,904 | -7,488 | -6,786 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,759 | -7,354 | -6,182 | -6,487 |
Cash | 31,124 | 32,326 | 39,230 | 11,118 |
Basic Shares | 22,546 | 22,234 | 21,520 | 14,121 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -381 | -1,814 | -1,270 | -815 |
EBITDA | -28,776 | -34,091 | -26,646 | -18,959 |
EBIT | -29,157 | -35,905 | -27,916 | -19,774 |
Net Income | -29,491 | -36,778 | -29,550 | -19,118 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -27,527 | -31,634 | -26,092 | -19,067 |
Cash | 39,230 | 31,230 | 51,829 | 18,820 |
Basic Shares | 15,416 | 11,548 | 3,790 | 31 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.42 |
2024-03-31 | -$0.36 |
2023-12-31 | -$0.38 |
2023-09-30 | -$0.48 |
